668387

Aspire Pharmaceuticals, Inc. — FEI 3003159106

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2010
Fiscal Year
2010
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Somerset, NJ (United States)

Citations

IDCFRDescription
1579721 CFR 111.553Written procedures - product complaint
1580121 CFR 111.560(b)Quality control, review, approve; investigate, follow-up
1592721 CFR 111.103Written procedures - quality control operations
1600821 CFR 111.135Quality control operations - product complaints; investigate